Navigation Links
Usage Of Oral Contraceptives Need Not Be Feared By SLE Patients

reaction when administered with estrogen. They also affected the B cells which plays a vital role in the disease process.

According to this study it is clearly seen that women suffering with inactive or stable SLE can take estrogen without any fear of increased reaction due to the disease. But on the other hand women suffering from a risk of blood clots are not supposed to take oral contraceptives as estrogen increases blood clot formation.

Hence in conclusion this study has improved the quality of the life of people with rheumatic disease
'"/>




Page: 1 2

Related medicine news :

1. Usage of coil better in brain haemorrhage
2. Oxygen Usage During Exercise Could Indicate Heart Problems
3. The Usage Of Anti-Inflammatory Drugs Questioned
4. Drug Pramipexole Usage Linked To Gambling Addiction In Parkinsons Patients
5. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
6. Safety Of Indian Sex Workers At Risk Due To Poor Condom Usage
7. Dummy Usage Raises Doubts.
8. More The Usage More The Growth In The Adult Brain.
9. Ignorance in the Usage of Pill Persists Among Many Women
10. Vaticans Council Reviews Condom Usage
11. Large Scale Free Access On Usage Of HIV Drugs Could Help In Fighting Its Spread
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Usage Oral Contraceptives Need Not Feared SLE Patients

(Date:3/2/2015)... 02, 2015 ProvidaStaff has ... its educational healthcare division to EDU Healthcare ... services to school systems and students nationwide. , “ProvidaStaff ... school districts throughout the country,” said Angela M. Lewis, ... a better organization and the introduction of EDU Healthcare ...
(Date:3/2/2015)... 02, 2015 Final Cut Pro X ... Volume 2 from Pixel Film Studios. , “The TranStatic Volume ... FCPX,” said Christina Austin, CEO of Pixel Film Studios. “TranStatic ... Final Cut Pro X editors toolbox.” , With TranStatic Volume ... with media altering static scrambling effects from Pixel Film Studios. ...
(Date:3/1/2015)... Clearwater, Florida (PRWEB) March 02, 2015 ... market their services and manage their practices ... offer an integrated all-inclusive solution. The ... development program and a medical practice management ... success and long-term financial sustainability. A referral ...
(Date:3/1/2015)... As residents and business owners in Southlake, Texas, ... Weaver, believe in supporting local organizations and causes. ... of Commerce, Carroll Independent School District and numerous ... for Southlake mayoral candidate Laura Hill: http://www.LauraHillforSouthlake.com ... campaign, the website combines images, videos and interactive ...
(Date:3/1/2015)... Birmingham, Clarkston, Lake Orion, Metamora, Michigan (PRWEB) March 01, 2015 ... BOTOX® , which is approved to treat Overactive Bladder (OAB) ... urgency and frequency in adults when another type of medication ... This is a different treatment option that takes another ... itself. , BOTOX® works on the nerves and ...
Breaking Medicine News(10 mins):Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2
... New England Journal of Medicine reports the latest research ... crossed in treating early breast //cancer successfully after having ... studies apparently looked into the effectiveness of adding the ... in early stages of breast cancer. Both studies ...
... Breast Cancer Campaign charity yesterday suggested that breast cancer may ... a long-term manageable disorder like diabetes and arthritis. ... to the significant developments in the diagnosis and treatment of ... recurrence of the cancer was reduced by new drugs like ...
... less inclined to commit suicide as compared to Whites was ... among black Americans. Scientists from the University of Michigan said ... ones own life happens to be the 11th leading cause ... that nearly one in 10 black Americans suffer from suicidal ...
... of coffee (3 cups a day) can affect a man's ... to show the adverse effect of modern life on the ... the US govt. has shown that modern men have only ... hampster (160 million/ml). The sperm count has declined worldwide over ...
... More than two-thirds of people who suffer from major ... work with their doctors //and try various treatments to ... taking different antidepressants or adding cognitive therapy to the ... led by UT Southwestern Medical Center, found that 67 ...
... According to British scientists, symptoms of schizophrenia can be ... Imperial College London conducted a study in 4 hospitals ... when they were encouraged to express themselves through music. ... psychological treatments can help people with schizophrenia, but these ...
Cached Medicine News:Health News:Breast Cancer may no longer be a killer disease 2Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 2Health News:Carefully Monitored Treatment Can Help Those Who Suffer from Depression 3
(Date:2/27/2015)... Feb. 27, 2015  Boston Scientific Corporation (NYSE: ... Barclays 2015 Annual Healthcare Conference on March 10 in ... Dan Brennan , executive vice president and chief financial ... Relations, will participate in a 25-minute question and answer ... approximately 1:05 p.m. ET. Following a 5-minute break, a ...
(Date:2/27/2015)...  PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... for the fourth quarter and full year ended December ... year for PTC. We are now a growing commercial-stage ... in the rare disease space," stated Stuart W. Peltz, ... proud to bring the first treatment for Duchenne muscular ...
(Date:2/27/2015)... NEWTON, Mass. and JERUSALEM ... privately-held biopharma company developing octreotide capsules, its lead product ... of a $70 million Series E financing round. Participants ... and Sofinnova Ventures, and an undisclosed blue chip public ... F2 Capital, 7 Med Health Ventures, Abingworth and ARCH ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3
... Vical Incorporated (Nasdaq:,VICL) today reported financial results for the ... of 2007 were $3.1 million, compared with,revenues of $7.3 ... loss for,the second quarter of 2007 was $8.2 million, ... $3.2 million, or $0.11 per share, for the second ...
... Vaccine to be tested with ... ImmuneRegen,s ... owned subsidiary of IR BioSciences Holdings, Inc.,(OTC Bulletin Board: IRBO), ... VaxGen Inc. (Pink Sheets: VXGN.PK). As part,of the agreement, ImmuneRegen ...
Cached Medicine Technology:Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 2Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 3Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 4Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 5Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs 6ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 2ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 3ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 4
... Bausch & Lomb PreserVision® AREDS formula ... and mineral supplement clinically proven effective in ... Age Related Eye Disease Study (AREDS). , ... and mineral supplement with the antioxidant vitamins ...
Ocuvite® vitamin and mineral supplements contain 2 mg of Lutein 8 times more than the leading multivitamins. Ocuvite also contains vitamin antioxidants A, C and E, as well as the minerals zinc, ...
HydroEye is an exclusive formulation designed to provide dry eye relief and support the body's natural tear formation. Like all ScienceBased Health formulations, it is produced in softgel form for ma...
Easy-to-use desktop QC data management solution...
Medicine Products: